Selecting the Best Pancreatic Cancer Surgeons and Hospitals in India for Australian Patients

Author:- Dr. Dheeraj Bojwani Date Created:- 14-08-2026

Pancreatic cancer surgery is one of the most technically demanding operations in all of surgery, and this guide is written for patients weighing where to access the genuine, focused volume this specific procedure rewards more than almost any other. In 24 years of guiding international patients into Indian hospitals, this is a field where Australia's own regulators have already reached the same conclusion this guide is built on: pancreatic surgery genuinely needs concentrated, high-volume expertise, and WA's health department has mandated exactly that within its own borders.

Healing Journeys of Australian Patients

Australian Patients Share Their Experience

Key Takeaways

• The guide focuses on the importance of genuine, concentrated pancreatic surgery volume, describing pancreatic cancer surgery as one of the most technically demanding operations. It notes that Australian health authorities have also recognised the importance of high-volume pancreatic surgery centres.
• Only two metropolitan cancer centres are permitted to perform pancreatic surgery for the entire state of Western Australia under the WA Health Department's policy. This is used to demonstrate how seriously surgical volume is treated for this procedure.
• The surgeon and team account for 55 out of 100 points, with genuine pancreatic resection volume receiving the highest individual weight of 17 points. Other important factors include hepatobiliary/pancreatic fellowship, honest assessment of tumour resectability, personal surgical involvement and transparent mortality and fistula-rate data.
• Hospital assessment accounts for 45 out of 100 points and includes a dedicated HPB multidisciplinary tumour board, sufficient ICU capacity for complex recovery, verifiable accreditation, pathology and biomarker turnaround, and complete records for the Australian oncologist.
• Queensland Health's own review found hospitals performing fewer than three pancreatic resections annually showed substantially greater outcome variation than high-volume dedicated centres. The guide therefore recommends asking for the surgeon's own annual pancreatic resection volume.
• The guide identifies four warning signs: vague annual surgical volume, pricing before imaging review, no dedicated HPB multidisciplinary board and reluctance to discuss mortality or fistula rates. It also recommends involving the Australian oncology team early and arranging continuing care before returning home.

Quick Facts

Treatment

Pancreatic Cancer Surgery

Country

India

Patients

Australian Patients

Main Procedure

Pancreatic Resection / Whipple Procedure

Key Decision

High-Volume Pancreatic Surgery

Selection Criteria

10 Weighted Criteria

Surgeon & Team Weight

55 out of 100

Hospital Weight

45 out of 100

Key Specialist

Hepatobiliary / Pancreatic Surgeon

Highest Criterion

Genuine Pancreatic Resection Volume

Key Qualification

HPB / Pancreatic Surgery Fellowship

Key Assessment

Tumour Resectability

Hospital Requirement

Dedicated HPB Multidisciplinary Tumour Board

ICU Focus

Extended Recovery Capacity

Key Data

Mortality & Fistula Rates

Important Support

Pathology & Biomarker Services

Warning Signs

Low Volume or No Transparent Outcomes

Follow-Up

Australian Oncologist

Required Records

Operative Record & Follow-Up Plan

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

In Brief

For Australian patients considering pancreatic cancer surgery in India, the guide recommends obtaining complete staging imaging and pathology before the first overseas consultation. Patients should prioritise a surgeon with substantial pancreatic resection volume, hepatobiliary/pancreatic fellowship training and direct involvement in surgery. The tumour should be assessed for genuine resectability based on the patient's actual imaging, rather than through a standardised or automatic recommendation. The hospital should have an HPB multidisciplinary tumour board, appropriate ICU capacity, verified accreditation and timely pathology and biomarker services. Before returning to Australia, patients should obtain the complete operative record and arrange follow-up with their Australian oncologist.

Why the volume threshold matters so much in this specific field

Get your full staging imaging and pathology together before your first overseas conversation, because this specific number matters. Queensland Health's own review found that hospitals performing fewer than three of these procedures a year showed significantly higher variation in clinical outcomes, a finding formally cited in the Royal Australasian College of Surgeons' national volume-outcome report.

Part one: judging the surgeon

1. Genuine volume in pancreatic resection. This is the single heaviest criterion in this guide. Ask for the surgeon's own annual volume, and compare it directly against the threshold Australian regulators themselves have flagged as too low.

2. Fellowship in hepatobiliary/pancreatic surgery. Ask where and when this was completed.

3. Honest resectability assessment, not default. Ask directly whether your specific tumour is genuinely resectable, and what the assessment was based on.

4. Personally operates. Insist on a video consultation with the surgeon who will actually operate, not a coordinator, before any deposit moves.

5. Candid mortality and fistula-rate data. Ask for the surgeon's own rate, a genuine, checkable measure of experience in this specific, high-risk procedure.

What the money actually looks like, and the honest trade-off worth knowing

This is worth being direct about. Published population-based research confirms this trade-off exists genuinely: high-volume centres achieve meaningfully better outcomes, but often at the cost of a longer wait. For patients facing this trade-off at home, exploring a genuinely high-volume centre abroad, without the domestic wait, is a reasonable way to get both.

Part two: judging the hospital

6. A dedicated HPB multidisciplinary tumour board. Ask whether your case is reviewed by a genuine hepatobiliary-pancreatic team before the plan is finalised.

7. ICU depth for extended recovery. This surgery carries a genuinely longer, more complex recovery. Confirm dedicated ICU capacity.

8. Accreditation you can verify yourself. JCI is the international arm of the body accrediting hospitals across the United States; NABH is India's national equivalent, recognised by the same global standards authority.

9. Pathology and biomarker turnaround. Ask how quickly results are available, since this affects both surgical planning and subsequent treatment decisions.

10. A record your Australian oncologist can use. Before you leave you should hold the full operative record and a specific follow-up plan.

Four Signals that Should Make You Pause

1. Vagueness about annual volume. This is the single most predictive factor in this field, and a confident centre states it plainly.

2. A price quoted before your imaging has been reviewed. Nobody can price or confirm resectability without seeing your specific case.

3. No dedicated HPB multidisciplinary board. This decision should never rest on one surgeon's opinion alone.

4. Reluctance to discuss mortality or fistula rates. These are standard, checkable outcome measures any genuine high-volume centre discusses openly.

Australia-specific considerations most patients miss

Tell your Australian surgical oncology team early, not after the fact. Most are more sympathetic to exploring a high-volume option than patients expect, especially given the documented wait-versus-outcome trade-off.

Arrange your ongoing oncology care before you leave. Confirm your Australian oncologist is willing to continue follow-up based on overseas surgical findings.

Apply for both visas together. Australian passport holders are eligible for India's electronic medical visa, with an e-medical attendant visa for whoever travels with you.

The Questions, in the Order You Should Ask Them

A closing word

Pancreatic cancer surgery rewards genuine, high volume more than almost any procedure in this series, and Australia's own health authorities have already reached that conclusion within their own borders. In 24 years of guiding patients through exactly this decision, weighting surgical volume as heavily as anything else is the single piece of advice I return to most often. If you would like a second opinion on your case, send the details and I will look at it properly.

Frequently Asked Questions by Australians about Pancreatic Cancer Surgeons and Hospitals in India

Why is surgical volume important in pancreatic cancer surgery?

The guide emphasises that pancreatic surgery is highly technically demanding and that Australian health authorities have recognised the importance of concentrated, high-volume expertise.

What is the most important criterion when choosing a surgeon?

Genuine pancreatic resection volume receives the highest individual weighting of 17 out of 100. Patients should ask for the surgeon's own annual volume.

What specialist qualification should patients look for?

The guide recommends hepatobiliary/pancreatic surgery fellowship training following specialist general surgical training.

How should tumour resectability be assessed?

Patients should ask whether their specific tumour is genuinely resectable and what the assessment is based on. The decision should follow review of the patient's actual imaging.

Should the operating surgeon personally review the case?

Yes. The guide recommends a video consultation with the surgeon who will actually operate rather than relying only on a coordinator before making a deposit.

Why should patients ask about mortality and fistula rates?

These are important outcome measures for pancreatic surgery. The guide recommends asking for the surgeon's own rates as a checkable indicator of experience with this high-risk procedure.

What hospital facilities are important?

Patients should confirm a dedicated HPB multidisciplinary tumour board, adequate ICU capacity for extended recovery and verified hospital accreditation.

Why are pathology and biomarker turnaround times important?

The guide notes that timely pathology and biomarker results can affect surgical planning and subsequent treatment decisions.

What warning signs should patients watch for?

The main warning signs are vague surgical volume, a price before imaging review, absence of an HPB multidisciplinary board and reluctance to discuss mortality or fistula rates.

What should Australian patients arrange before returning home?

Patients should arrange ongoing oncology care with their Australian team and obtain the complete operative record and a specific follow-up plan before leaving India.

Sources

• Royal Australasian College of Surgeons, Volume-Outcome Relationships: Pancreaticoduodenectomy (Whipple Procedure), 2019 — surgeons.org
• Yau et al., Transitioning to a high volume centre for Whipple pancreaticoduodenectomy in Western Australia, ANZ Journal of Surgery, 2022 — onlinelibrary.wiley.com
• National Medical Commission — nmc.org.in
• National Accreditation Board for Hospitals & Healthcare Providers — nabh.co
• High Commission of India, e-Visa — indianvisaonline.gov.in

Page Summary

This five-page guide helps Australian patients evaluate pancreatic cancer surgeons and hospitals in India, with strong emphasis on genuine surgical volume. It explains why high-volume pancreatic centres are important and highlights Australia's own focus on concentrated expertise. The guide uses 10 weighted criteria, with 55 points for the surgeon and team and 45 for the hospital. Key factors include pancreatic resection volume, HPB fellowship, resectability assessment, mortality and fistula data, multidisciplinary tumour review and ICU capacity. It also covers pathology turnaround, accreditation and Australian oncology follow-up.

Citation Block

Field	Information
Topic	Pancreatic Cancer Surgeons & Hospitals
Treatment	Pancreatic Cancer Surgery
Country	India
Patients	Australian Patients
Main Procedure	Pancreatic Resection / Whipple
Key Specialist	Hepatobiliary / Pancreatic Surgeon
Selection Criteria	10 Weighted Criteria
Surgeon & Team Weight	55 out of 100
Hospital Weight	45 out of 100
Highest Criterion	Pancreatic Resection Volume
Key Qualification	HPB / Pancreatic Fellowship
Key Assessment	Tumour Resectability
Outcome Data	Mortality & Fistula Rates
Hospital Requirement	HPB Multidisciplinary Tumour Board
ICU Requirement	Extended Recovery Capacity
Key Support	Pathology & Biomarker Turnaround
Warning Signs	Low Volume or Unclear Outcomes
Follow-Up	Australian Oncologist